Peter Lichtlen

2014

In 2014, Peter Lichtlen earned a total compensation of $1.1M as Chief Medical Officer at Sucampo Pharmaceuticals, a 99% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$88,968
Option Awards$471,008
Salary$195,084
Other$355,302
Total$1,110,362

Lichtlen received $471K in option awards, accounting for 42% of the total pay in 2014.

Lichtlen also received $89K in non-equity incentive plan, $195.1K in salary and $355.3K in other compensation.

Rankings

In 2014, Peter Lichtlen's compensation ranked 7,119th out of 13,032 executives tracked by ExecPay. In other words, Lichtlen earned more than 45.4% of executives.

ClassificationRankingPercentile
All
7,119
out of 13,032
45th
Division
Manufacturing
2,620
out of 4,966
47th
Major group
Chemicals And Allied Products
894
out of 1,686
47th
Industry group
Drugs
703
out of 1,365
49th
Industry
Pharmaceutical Preparations
540
out of 1,043
48th
Source: SEC filing on April 18, 2016.

Lichtlen's colleagues

We found five more compensation records of executives who worked with Peter Lichtlen at Sucampo Pharmaceuticals in 2014.

2014

Peter Greenleaf

Sucampo Pharmaceuticals

Chief Executive Officer

2014

Peter Kiener

Sucampo Pharmaceuticals

Chief Scientific Officer

2014

Matthias Alder

Sucampo Pharmaceuticals

General Counsel

2014

Max Donley

Sucampo Pharmaceuticals

EVP, Global Human Resources, Information Technology and Strategy

2014

Andrew Smith

Sucampo Pharmaceuticals

Chief Financial Officer

You may also like